Participation in cellular prostaglandin synthesis of type-II phospholipase A2 secreted and anchored on cell-surface heparan sulfate proteoglycan.

Rat-liver-derived BRL-3A cells, which express both type-II phospholipase A2 (PLA2) and cytosolic PLA2 (cPLA2), generated prostaglandin E2 (PGE2) in the presence of fetal calf serum. When the cells were treated with tumor necrosis factor (TNF), PGE2 generation was greatly stimulated. The production of PGE2 observed in both cases was suppressed by a type-II PLA2-specific inhibitor, thielocin A1. Appreciable amounts of type-II PLA2 were released into the medium from the TNF-stimulated cells when heparin was added extracellularly. The release of type-II PLA2 from TNF-stimulated cells was also found in the presence of heparan sulfate or dextran sulfate, whereas other glycosaminoglycans showed no effects under the same conditions. These findings suggest that type-II PLA2 expressed in BRL-3A cells mostly associates with the cell surface by binding to cellular heparan sulfate proteoglycan. Removal of cell-surface-associated type-II PLA2, by either extracellular addition of heparin or by prior treatment of the BRL-3A cells with heparitinases, resulted in marked reduction of PGE2 synthesis in the cells. Exposure of BRL-3A cells to thrombin also induced the apparent secretion of type-II PLA2, and thrombin-stimulated PGE2 generation was suppressed by heparin effectively. Type-II PLA2 secreted and attached to heparan sulfate on the cell surface may therefore play an essential role in PGE2 synthesis by BRL-3A cells.

[1]  R. Heller,et al.  Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Roger J. Davis,et al.  cPLA2 is phosphorylated and activated by MAP kinase , 1993, Cell.

[3]  M. Murakami,et al.  Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. Possible participation of cytosolic and extracellular type II phospholipases A2. , 1993, The Journal of biological chemistry.

[4]  T. Hendriks,et al.  Collagen synthesis in fibroblasts from human colon: regulatory aspects and differences with skin fibroblasts. , 1992, Gut.

[5]  M. Murakami,et al.  Release of 14-kDa group-II phospholipase A2 from activated mast cells and its possible involvement in the regulation of the degranulation process. , 1992, European journal of biochemistry.

[6]  M. Goppelt‐Struebe,et al.  Glucocorticoids inhibit TNFα-induced cytosolic phospholipase A2 activity , 1992 .

[7]  K. Williams,et al.  Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. , 1992, The Journal of biological chemistry.

[8]  L. L. Lin,et al.  Cytosolic phospholipase A2 is coupled to hormonally regulated release of arachidonic acid. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Schalkwijk,et al.  Interleukin-1 beta- and forskolin-induced synthesis and secretion of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by transforming growth factor-beta 2. , 1992, The Journal of biological chemistry.

[10]  M. Murakami,et al.  Detection of three distinct phospholipases A2 in cultured mast cells. , 1992, Journal of biochemistry.

[11]  M. Murakami,et al.  Eicosanoid generation from antigen‐primed mast cells by extracellular mammalian 14‐kDa group II phospholipase A2 , 1991, FEBS letters.

[12]  K. Matsumoto,et al.  Thielocins A1 alpha and A1 beta, novel phospholipase A2 inhibitors from ascomycetes. , 1991, The Journal of antibiotics.

[13]  J. Wijkander,et al.  An 100-kDa arachidonate-mobilizing phospholipase A2 in mouse spleen and the macrophage cell line J774. Purification, substrate interaction and phosphorylation by protein kinase C. , 1991, European journal of biochemistry.

[14]  G. Béréziat,et al.  Type II phospholipase A2 recombinant overexpression enhances stimulated arachidonic acid release. , 1991, Biochemical and biophysical research communications.

[15]  K. Inoue,et al.  Augmentation of prostaglandin E2 production by mammalian phospholipase A2 added exogenously. , 1991, Journal of biochemistry.

[16]  J. D. Clark,et al.  A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP , 1991, Cell.

[17]  S. Oka,et al.  Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression. , 1991, The Journal of biological chemistry.

[18]  Keizō Inoue,et al.  Purification and characterization of human platelet phospholipase A2 which preferentially hydrolyzes an arachidonoyl residue , 1991, FEBS letters.

[19]  K. Inoue,et al.  Purification and characterization of rabbit platelet cytosolic phospholipase A2. , 1991, Biochimica et biophysica acta.

[20]  J. Manetta,et al.  The Ca2(+)-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells. , 1991, The Journal of biological chemistry.

[21]  C. Stoner,et al.  Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. , 1991, The Journal of biological chemistry.

[22]  M. Murakami,et al.  Exacerbation of rat adjuvant arthritis by intradermal injection of purified mammalian 14‐kDa group II phospholipase A2 , 1990, FEBS letters.

[23]  M. Murakami,et al.  Immunochemical detection of 'platelet type' phospholipase A2 in the rat. , 1990, Biochimica et biophysica acta.

[24]  H. Sakagami,et al.  Dependence of cytokine-induced human myelogenous leukemic cell differentiation on the type of serum in the medium. , 1990, Anticancer research.

[25]  H. Teraoka,et al.  Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells , 1990, FEBS letters.

[26]  R. Kramer,et al.  Structure and properties of a human non-pancreatic phospholipase A2. , 1989, The Journal of biological chemistry.

[27]  M. Murakami,et al.  Purification of rabbit platelet secretory phospholipase A2 and its characteristics. , 1989, Journal of biochemistry.

[28]  K. Inoue,et al.  Purification and characterization of extracellular phospholipase A2 from human synovial fluid in rheumatoid arthritis. , 1989, Journal of biochemistry.

[29]  C. Leslie,et al.  Properties and purification of an arachidonoyl-hydrolyzing phospholipase A2 from a macrophage cell line, RAW 264.7. , 1988, Biochimica et biophysica acta.

[30]  M. Murakami,et al.  Monoclonal antibodies against rat platelet phospholipase A2. , 1988, Journal of biochemistry.

[31]  M. Tomita,et al.  The primary structure of rat platelet phospholipase A2. , 1988, Journal of biochemistry.

[32]  T. Hori,et al.  Effects of tumor necrosis factor on cell growth and expression of transferrin receptors in human fibroblasts. , 1988, Cell structure and function.

[33]  M. Tomita,et al.  Purification and characterization of extracellular phospholipase A2 from peritoneal cavity of caseinate-treated rat. , 1987, Journal of biochemistry.

[34]  S. Nojima,et al.  Purification and characterization of phospholipase A2 released from rat platelets. , 1987, Journal of Biochemistry (Tokyo).

[35]  J. Stow,et al.  Heparan sulfate proteoglycans are concentrated on the sinusoidal plasmalemmal domain and in intracellular organelles of hepatocytes , 1985, The Journal of cell biology.

[36]  M. Rechler,et al.  Proliferation of buffalo rat liver cells in serum-free medium does not depend upon multiplication-stimulating activity (MSA) , 1977, Cell.

[37]  V. Wray,et al.  The isolation and characterization of plasma membranes from cultured cells. II. The chemical composition of membrane isolated from uninfected and oncogenic RNA virus-converted parenchyma-like cells. , 1971, Biochimica et biophysica acta.

[38]  M. Murakami,et al.  Immunochemical detection of arachidonoyl-preferential phospholipase A2. , 1992, Journal of biochemistry.